Protease Inhibitors
The Basics
- Characteristics of Protease Inhibitors (PIs) (PDF) (January 10, 2011)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents. For the full guidelines, click here (PDF).
From AIDSinfo
- Labeling for Protease Inhibitors Updated With New Info on Drug-Drug Interactions (April 27, 2010)
From U.S. Food and Drug Administration
- Protease Inhibitors (August 15, 2006)
From AIDS Treatment Data Network
- Pharmacokinetics: The Protease Inhibitor Drugs (Winter 2004/2005)
Pharmacist James D. Scott explains how protease inhibitors work, and how they might interact with other HIV meds.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- New HIV Protease Inhibitors: New Options in the PI Class for Treatment-Naive Persons (Spring 2004)
To read PDF, click here.
In Resolute!, from PWA Coalition Colorado
- HIV 101: Antiretroviral Agents Dosing and Administration Recommendations: PIs (January 2002)
To read PDF, click here.
In HEPP News, from Brown Medical School
- Summary of PI Dosing and Administration Recommendations (November 2001)
In HEPP News, from Brown Medical School
- Dual Protease Inhibitors Gain Ground (Spring 2001)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Real Life Situations ... (March 2001)
In WISE Words, from Project Inform
- X-Factors (November/December 2000)
Protease inhibitors may have unexpected benefits.
In GMHC Treatment Issues, from Gay Men's Health Crisis
VIEW ALL ARTICLES
|
Advertisement
|
Email
Glossary
